Ingredient

Ruxolitinib Phosphate

Ruxolitinib phosphate is an antineoplastic agent used for the treatment of myeloproliferative diseases.

All medicines
4
Single ingredient
4
Prescription medication
4

MFDS ingredient code M256115

What does it do?

Ruxolitinib phosphate is an antineoplastic agent that selectively inhibits the enzymes JAK1 and JAK2. It is primarily used to treat myeloproliferative diseases such as myelofibrosis and polycythemia vera. This class of drugs aims to regulate abnormal blood cell proliferation.

Ruxolitinib phosphate blocks the activity of the JAK1 and JAK2 enzymes in the body, thereby inhibiting abnormal signaling. This helps control the growth of excessively proliferating blood cells and reduces inflammatory responses. As a result, it aids in the relief of symptoms and the progression of myeloproliferative diseases.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Ruxolitinib phosphate is characterized by its ability to simultaneously inhibit JAK1 and JAK2 among JAK enzymes. It has been proven effective for specific myeloproliferative diseases compared to other JAK inhibitors. Additionally, it has the advantage of being an oral formulation, making it convenient to take.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.